雷多克斯稳态干扰剂增强了对协同光热/化学动力学疗法的杯灭效应
Zhen Liu1, Junhong Ling1, Nan Wang1
1School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, PR China.
Journal of colloid and interface science
|September 5, 2024
概括
新型铜化纳米颗粒结合了化学动力学疗法 (CDT) 和光热疗法 (PTT) 以加强癌症治疗. 这些纳米粒子诱导了亡和亡,提供了一个有前途的协同治疗策略.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 化学动力学疗法 (CDT) 和光热疗法 (PTT) 是有前途的癌症治疗方法.
- 结合CDT和PTT可以提高抗瘤功效.
- 开发用于协同治疗癌症的新型纳米材料至关重要.
研究的目的:
- 开发一种与氨酸 (Cu-PDA-HA NPs) 功能化的新型铜化聚多巴胺 (PDA) 纳米粒子.
- 研究结合CDT和PTT与亡和亡诱导的协同治疗效应.
- 探索Cu-PDA-HANP在向癌症治疗中的潜力.
主要方法:
- 合成和表征Cu-PDA-HA NPs. 的合成和表征.
- 在实验室中评估纳米粒子降解,离子释放和细胞死亡诱导 (细胞亡和细胞亡).
- 在体内研究以评估光热效应,瘤积累和治疗疗效.
主要成果:
- Cu-PDA-HA NPs在瘤微环境中引发了降解,释放了Cu2+离子.
- 释放的Cu2+离子催化了芬顿式反应,产生CDT的基,并诱导了亡.
- Cu-PDA-HA NPs表现出显著的光热效应,增强氧化应激并通过降低Fe-S集群蛋白的调节来激活cuproptosis.
结论:
- Cu-PDA-HA NPs为协同的癌症治疗提供了一个多功能平台.
- 开发的纳米颗粒有效地结合了CDT,PTT,亡和cuproptosis.
- 这项研究提出了一种新的策略,用于设计纳米粒子,以提高抗瘤功效.
更多相关视频
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
1.9K
09:12[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
Published on: May 21, 2019
9.2K
相关概念视频
Electron Transport Chain: Complex I and II
12.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Oxidation of Phenols to Quinones
2.9K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
2.9K
